A 12-MONTH STUDY OF THE EFFECTS OF ORAL ZIDOVUDINE ON NEURODEVELOPMENTAL FUNCTIONING IN A COHORT OF VERTICALLY HIV-INFECTED INNER-CITY CHILDREN

被引:24
作者
NOZYCE, M
HOBERMAN, M
ARPADI, S
WIZNIA, A
LAMBERT, G
DOBROSZYCKI, J
CHANG, CJ
STLOUIS, Y
机构
[1] COLUMBIA UNIV,ST LUKES ROOSEVELT HOSP CTR,COLL PHYSICIANS & SURGEONS,NEW YORK,NY
[2] BRONX LEBANON HOSP CTR,DEPT PEDIAT,NEW YORK,NY
[3] ALBERT EINSTEIN COLL MED BRONX,NEW YORK,NY
关键词
NEURODEVELOPMENT; PEDIATRICS; HIV INFECTION; COGNITION; ZIDOVUDINE;
D O I
10.1097/00002030-199405000-00009
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: To examine the effects of oral zidovudine on the neurodevelopmental functioning of HIV-infected children. Methods: Oral zidovudine was administered to 54 symptomatic children with vertically transmitted HIV infection (Centers for Disease Control and Prevention class P2). All children were recruited from an inner-city pediatric HIV/AIDS outpatient clinic and ranged in age from 2 months to 12 years and 11 months (mean age, 3 years) at entry. Neurodevelopmental functioning, height and weight, and lymphocyte subpopulation data were ascertained for all the children pretherapy, and 6 and 12 months post-therapy initiation. Results: Analysis of the 6- and 12-month post-initiation drug data found no significant change in neurodevelopmental functioning. Height and weight percentiles remained the same or improved in the majority of children. CD4+ cell counts declined over the treatment period with CD4+ counts < 500 x 10(6)/l observed in 15% of the children pre-therapy, and 33% after 1 year. Conclusion: In contrast with previously published data, the present study observed no improvement in neurodevelopmental functioning in HIV-infected children treated with oral zidovudine.
引用
收藏
页码:635 / 639
页数:5
相关论文
共 22 条
[1]  
[Anonymous], 2014, TECHNICAL INTERPRETI
[2]  
Bayley N., 1969, BAYLEY SCALES INFANT
[3]   PEDIATRIC ACQUIRED IMMUNODEFICIENCY SYNDROME - NEUROLOGIC SYNDROMES [J].
BELMAN, AL ;
DIAMOND, G ;
DICKSON, D ;
HOROUPIAN, D ;
LLENA, J ;
LANTOS, G ;
RUBINSTEIN, A .
AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1988, 142 (01) :29-35
[4]   EFFECT OF CONTINUOUS-INFUSION ZIDOVUDINE THERAPY ON NEUROPSYCHOLOGICAL FUNCTIONING IN CHILDREN WITH SYMPTOMATIC HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION [J].
BROUWERS, P ;
MOSS, H ;
WOLTERS, P ;
EDDY, J ;
BALIS, F ;
POPLACK, DG ;
PIZZO, PA .
JOURNAL OF PEDIATRICS, 1990, 117 (06) :980-985
[5]  
DENNY TN, 1990, PEDIATR RES, V27, P155
[6]  
DIAMOND GW, 1989, MENT RETARD, V27, P213
[7]  
DURAKO S, 1991, 6 INT C AIDS FLOR
[8]  
HADEED AJ, 1989, PEDIATRICS, V84, P205
[9]   PHYSICAL GROWTH - NATIONAL-CENTER-FOR-HEALTH-STATISTICS PERCENTILES [J].
HAMILL, PVV ;
DRIZD, TA ;
JOHNSON, CL ;
REED, RB ;
ROCHE, AF ;
MOORE, WM .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1979, 32 (03) :607-629
[10]  
KAYE K, 1989, NEW YORK STATE J MED, V89, P256